Quantification of Imipramine, Amitriptyline and their Major Metabolites in Urine Samples of Depressed Patients by Gas Chromatography-Mass Spectrometry

Document Type: Original Article

Authors

Department of Chemistry, School of Physical Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, Cape Coast, Ghana

Abstract

Biotransformation of antidepressant drugs is said to affect their pharmacological profile and subsequently alter their treatment efficacies. Imipramine and amitriptyline are the major drugs used for the management of manic depression at the Ankaful psychiatric hospital in Ghana. Recent reports have shown that some patients stay longer on this therapy than expected, while others do not get well at all. Herein, we report a modified solid phase extraction (SPE) method for the extraction of these antidepressant drugs; imipramine, amitriptyline and their respective metabolites, desipramine and 10-hydroxyamitriptyline from urine samples of five adult manic depressed patients. The compounds were simultaneously analyzed by gas chromatography-mass spectrometry (GC-MS). The calibration curves were linear over a range of 10-100 µg/L for all the analytes with the square of the regression coefficient (R2) ranging from 0.990 to 0.997. Analyses of the drugs and their respective metabolites over a 40 day period gave an average of 3.65 µg/L 10-hydroxyamitriptyline with negligible levels of amitriptyline. An average of 27.01 µg/L desipramine was also recorded against 10.30 µg/L of imipramine. These high levels of metabolites and relatively low amounts of the parent drugs recorded in the urine samples could be the main cause of the patients staying longer on the therapy and the resultant abscondment of one of them.

Keywords


[1]      Viola G, Miolo G, Vedaldi D, Dall’Acqua F (2000) In vitro studies of the phototoxic potential of the antidepressant drugs amitriptyline and imipramine. Il Farmaco 55 (3):211-218

[2]      Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews (4)

[3]      McCleane G (2008) Antidepressants as analgesics. CNS drugs 22 (2):139-156

[4]      Coluzzi F, Mattia C (2005) Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Current pharmaceutical design 11 (23):2945-2960

[5]      Reynolds IJ, Miller RJ (1988) Tricyclic antidepressants block N‐methyl‐D‐aspartate receptors: similarities to the action of zinc. British journal of pharmacology 95 (1):95-102

[6]      Jain AK, Thomas NS, Panchagnula R (2002) Transdermal drug delivery of imipramine hydrochloride.: I. Effect of terpenes. Journal of controlled release 79 (1-3):93-101

[7]      Breyer‐Pfaff U (2004) The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man. Drug metabolism reviews 36 (3-4):723-746

[8]      Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M (2003) Nortriptyline for treatment-resistant depression. The Journal of clinical psychiatry

[9]      Hughes JR, Stead LF, Lancaster T (2005) Nortriptyline for smoking cessation: a review. Nicotine & tobacco research 7 (4):491-499

[10]    Rana S, Uralets VP, Ross W (2008) A new method for simultaneous determination of cyclic antidepressants and their metabolites in urine using enzymatic hydrolysis and fast GC-MS. Journal of analytical toxicology 32 (5):355-363

[11]    Nusser E, Nill K, Breyer-Pfaff U (1990) Enantiomer analysis of E-and Z-10-hydroxyamitriptyline in human urine. Journal of Chromatography B: Biomedical Sciences and Applications 528:163-171

[12]    Gram LF, Bjerre M, Kragh‐Sørensen P, Kvinesdal B, Molin J, Pedersen OL, Reisby N (1983) Imipramine metabolites in blood of patients during therapy and after overdose. Clinical Pharmacology & Therapeutics 33 (3):335-342

[13]    Flores JR, Nevado JB, Salcedo AC, Diaz MC (2005) Nonaqueous capillary electrophoresis method for the analysis of tamoxifen, imipramine and their main metabolites in urine. Talanta 65 (1):155-162

[14]    Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM (2002) Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Archives of General Psychiatry 59 (3):233-239

[15]    Ma S, Zhu M (2009) Recent advances in applications of liquid chromatography–tandem mass spectrometry to the analysis of reactive drug metabolites. Chemico-biological interactions 179 (1):25-37

[16]    Flanagan RJ, Taylor A, Watson ID, Whelpton R (2007) Fundamentals of Analytical Toxicology. John Wiley & Sos, Ltd, England

[17]    Watson DG (2012) Phamaceutical Analysis "A textbook for Pharmacy Students and Pharmaceutical Chemists". 3rd edn. Churchhill livingstone Elsevier, United Kingdom

[18]    Xu AQ, Madden TL (2011) ANALYTICAL METHODS FOR THERAPEUTIC DRUG MONITORING AND TOXICOLOGY. John Wiley & Sons, Inc.,, Hoboken, New Jersey

[19]    Almeida AMd, Castel-Branco MM, Falcao A (2002) Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. Journal of Chromatography B 774 (2):215-222

[20]    Chen A, Wing Y, Chiu H, Lee S, Chen C, Chan K (1997) Simultaneous determination of imipramine, desipramine and their 2-and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 693 (1):153-158


Volume 1, Issue 1
Summer and Autumn 2019
Pages 31-34
  • Receive Date: 22 September 2019
  • Revise Date: 04 November 2019
  • Accept Date: 04 November 2019